ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$TGTX:NASDAQ · TG THERAPEUTICS INC

Sector: health

Conviction from: NASDAQ

52-week range: 26.7668.03

TG Therapeutics is a biopharmaceutical company that develops and commercializes treatments for B-cell diseases and multiple sclerosis, including its anti-CD20 therapy.

4 tracked filer(s) hold this · 1 opened, 2 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 58 — mean of 4 scored holder(s) · buyers (new/add) avg 64. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Larry Robbins / Glenview61New buy4,800$267,7440.0%
Bridgewater55Added +36%586,631$32,722,2770.1%
Steve Cohen / Point7275Added +53%560,269$31,251,8050.0%
Ancora42Trimmed -17%250$13,9450.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

4 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-22Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentSELL$15.001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$50,001 - $100,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.